As per the latest Clinical Research Organisation (CLRO) Market Report by Frost & Sullivan (India), India is becoming an attractive destination for clinical and preclinical research outsourcing supported by quality scientific capability, the emergence of the biosimilars industry, increased demand for complex generics and availability of a large number of patient volunteers. A key player of the Indian CLRO market, Ahmedabad-based Veeda Clinical Research is all set to capitalise on the growing R&D budget of the global pharmaceutical firms. In conversation with BioSpectrum, Ajay Tandon, Managing Director, Veeda Clinical Research, Ahmedabad reveals the company’s future plans.
China
United-states
India
America
Pranab-mody
Sanjiv-das
Nikhil-vora
Arjun-bhartia
Indian-clros
Havells-india-family-office
Sabre-partners
Sixth-sense-ventures